Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Artemis Medicare

₹179 -14.2 | 7.3%

Market Cap ₹2451 Cr.

Stock P/E 49.5

P/B 6.4

Current Price ₹179

Book Value ₹ 27.8

Face Value 1

52W High ₹199

Dividend Yield 0.25%

52W Low ₹ 79.2

Artemis Medicare Research see more...

Overview Inc. Year: 2004Industry: Hospital & Healthcare Services

Artemis Medicare Services Ltd manages and operates multi-speciality hospitals in India and across the world. The company offers scientific and surgical intervention; and inpatient and outpatient offerings. It additionally operates Artemis Hospital, a 395 bed multi-speciality health facility placed in Gurugram, India. The business enterprise changed into incorporated in 2004 and is based in Gurugram, India.

Read More..

Artemis Medicare Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Artemis Medicare Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 144 149 167 187 187 195 210 225 219 225
Other Income 1 1 2 1 1 2 1 2 2 2
Total Income 145 151 170 189 189 198 211 227 221 227
Total Expenditure 126 132 148 164 162 170 182 191 186 187
Operating Profit 19 18 22 25 27 28 29 37 34 40
Interest 3 4 4 5 5 5 7 8 8 9
Depreciation 6 6 7 7 8 9 9 10 10 11
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 10 8 11 13 13 14 13 19 16 20
Provision for Tax 4 -5 2 4 3 3 3 5 5 6
Profit After Tax 6 13 8 9 10 11 10 14 12 14
Adjustments 0 0 0 0 0 -0 0 0 -0 -0
Profit After Adjustments 6 13 8 9 10 11 10 14 12 14
Adjusted Earnings Per Share 0.5 1 0.6 0.7 0.8 0.8 0.7 1 0.9 1

Artemis Medicare Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 547 565 408 555 737 879
Other Income 4 5 4 5 7 7
Total Income 551 570 412 560 745 886
Total Expenditure 483 504 373 488 643 746
Operating Profit 68 66 39 71 101 140
Interest 11 13 13 12 20 32
Depreciation 20 23 22 22 31 40
Exceptional Income / Expenses 0 0 3 0 0 0
Profit Before Tax 37 31 8 37 51 68
Provision for Tax 16 11 1 6 13 19
Profit After Tax 20 19 6 31 38 50
Adjustments 0 0 0 0 1 0
Profit After Adjustments 20 20 6 32 39 50
Adjusted Earnings Per Share 0 1.5 0.5 2.4 2.9 3.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 33% 9% 0% 0%
Operating Profit CAGR 42% 15% 0% 0%
PAT CAGR 23% 26% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 124% 98% NA% NA%
ROE Average 12% 9% 9% 9%
ROCE Average 13% 10% 11% 11%

Artemis Medicare Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 293 313 320 359 403
Minority's Interest -0 0 2 2 5
Borrowings 53 66 108 161 214
Other Non-Current Liabilities 31 49 61 65 103
Total Current Liabilities 177 158 118 138 206
Total Liabilities 554 586 609 726 930
Fixed Assets 381 393 383 489 605
Other Non-Current Assets 61 76 116 110 155
Total Current Assets 113 118 109 127 170
Total Assets 554 586 609 726 930

Artemis Medicare Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 4 9 12 19 16
Cash Flow from Operating Activities 40 56 27 60 127
Cash Flow from Investing Activities -50 -26 -37 -107 -158
Cash Flow from Financing Activities 14 -27 18 44 38
Net Cash Inflow / Outflow 5 2 8 -3 7
Closing Cash & Cash Equivalent 9 12 19 16 23

Artemis Medicare Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0 1.5 0.49 2.4 2.88
CEPS(Rs) 0 3.18 2.09 4.05 5.15
DPS(Rs) 0 0 0 0 0.45
Book NAV/Share(Rs) 0 18.68 19.17 21.51 24.43
Core EBITDA Margin(%) 11.68 10.88 8.62 11.98 12.74
EBIT Margin(%) 8.74 7.69 5.01 8.86 9.53
Pre Tax Margin(%) 6.72 5.42 1.84 6.7 6.86
PAT Margin (%) 3.73 3.44 1.51 5.66 5.15
Cash Profit Margin (%) 7.4 7.45 6.78 9.66 9.36
ROA(%) 3.68 3.41 1.03 4.71 4.59
ROE(%) 9.5 8.43 2.46 11.66 12.41
ROCE(%) 13.96 12.64 5.63 11.47 13.34
Receivable days 52.5 50.13 58.68 42.15 41.25
Inventory Days 4.63 5.71 9.11 7.24 6.53
Payable days 205.99 194.88 206.67 138.01 141.52
PER(x) 0 9.23 45.31 19.1 23.65
Price/Book(x) 0 0.74 1.16 2.13 2.79
Dividend Yield(%) 0 0 0 0 0.66
EV/Net Sales(x) 0.19 0.47 0.96 1.38 1.5
EV/Core EBITDA(x) 1.5 4.01 10.07 10.7 10.89
Net Sales Growth(%) 0 3.39 -27.72 35.85 32.92
EBIT Growth(%) 0 -9.04 -52.9 140.33 42.97
PAT Growth(%) 0 -4.55 -68.35 409.76 21.05
EPS Growth(%) 0 0 -67.23 390.47 19.75
Debt/Equity(x) 0.53 0.4 0.5 0.64 0.74
Current Ratio(x) 0.64 0.74 0.92 0.92 0.83
Quick Ratio(x) 0.6 0.68 0.84 0.83 0.76
Interest Cover(x) 4.34 3.39 1.58 4.11 3.57
Total Debt/Mcap(x) 0 0.54 0.43 0.3 0.26

Artemis Medicare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 69.82 69.82 69.59 69.27 68.92 68.92 68.03 68.03 68.03 68.03
FII 0 0 0 0 0 0 0.07 0.09 0.11 0.1
DII 8.59 8.47 8.25 8.21 8.42 8.65 8.59 8.69 9.13 9.78
Public 21.59 21.71 22.17 22.52 22.66 22.44 23.31 23.18 22.72 22.08
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

Cons

  • Company has a low return on equity of 9% over the last 3 years.
  • Debtor days have increased from 138.01 to 141.52days.
  • Stock is trading at 6.4 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Artemis Medicare News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....